Tallac Therapeutics

0 followers


Tallac Therapeutics is a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer. Tallac’s pipeline of immunotherapy candidates are derived from the company’s novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform to deliver a poten... Read more

Employees

11-50

Links


Org chart

Curtis Hecht
Chief Business Officer
Mark Karbarz
Executive Director of Biologics Development, Head of CMC
Pavel Strop
Vice President, Head of Research